56 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Midatech Pharma PLC-ADR MTP shares jumped 263.5% to $6.18 after the company announced a research collaboration for the Q-Sphera platform with a European pharmaceutical company.
• Owens & Minor, Inc. OMI gained 78.7% to $14.19 after the company announced preliminary results for the second quarter. Owens & Minor sees preliminary Q2 adjusted EPS of $0.18-$0.20.
• Immuron Limited IMRN shares climbed 64.9% to $17.15 after the company said its IMM-124E — used to manufacture its flagship commercially available and over-the-counter gastrointestinal and digestive health immune supplements Travelan and Protectyn — has demonstrated neutralizing activity against the severe acute respiratory syndrome coronavirus-2, the virus that causes COVID-19.
• New Age Beverages Corporation NBEV rose 55% to $2.69 after the company agreed to combine with ARIIX and 4 additional e-commerce/direct selling companies.
• Tonix Pharmaceuticals Holding Corp. TNXP rose 38.1% to $2.1404 after jumping over 91% in the previous session. Last Thursday, Tonix Pharmaceuticals reported a research collaboration to develop precision medicine techniques for coronavirus vaccines and therapeutics.
• Intec Pharma Ltd. NTEC shares rose 36% to $0.5247 after gaining around 12% on Monday.
• Onconova Therapeutics, Inc. ONTX rose 27.5% to $1.39 after gaining over 34% on Monday.
• Novan, Inc. NOVN rose 25% to $0.8625 after climbing 12% on Monday.
• Actinium Pharmaceuticals, Inc. ATNM rose 24.5% to $0.56 after surging over 12% on Monday.
• Bionano Genomics, Inc. BNGO rose 21% to $0.8287. Bionano shares climbed 11% on Monday after the company highlighted publication from International Consortium using the company’s imaging in genetic disease patients.
• Arlo Technologies, Inc. ARLO gained 20.9% to $3.36 after the company reported an agreement with Securitas USA to integrate Smartcloud SaaS solution.
• Ocean Bio-Chem, Inc. OBCI shares surged 21% to $17.89. Last week, Ocean Bio-Chem reported Q2 sales of $15.7 million.
• Hibbett Sports, Inc. HIBB shares rose 20.4% to $27.06 after the company issued strong sales update for the second quarter. The company said Q2 comparable store sales are expected to increase in excess of 70%, while 1H comparable store sales are projected to increase by roughly 20%.
• OPKO Health, Inc. OPK rose 20% to $5.93 after the company said its unit BioReference Lab was awarded a contract to provide commercial surge capacity testing for COVID-19 emergency response to the Centers for Disease Control and Prevention.
• Genetic Technologies Limited GENE surged 18.3% to $5.10 after dropping 24% on Monday.
• Corvus Pharmaceuticals, Inc. CRVS shares rose 17.8% to $5.09.
• AYRO Inc AYRO gained 17.6% to $5.99 as the company received initial order for new All-electric mobile food vehicles.
• Nabors Industries Ltd. NBR climbed 16.5% to $36.04. Nabors is expected to release Q2 earnings on July 28, 2020.
• Potbelly Corporation PBPB gained 16.1% to $2.53 after the company named Robert D. Wright as President and CEO.
• Canaan Inc. CAN rose 16% to $2.62 after climbing about 18% on Monday.
• Eyenovia, Inc. EYEN rose 15.6% to $3.40.
• Qualigen Therapeutics, Inc. QLGN rose 15.5% to $5.73 after surging over 13% on Monday.
• Guess', Inc. GES surged 15.5% to $10.67.
• Inflarx NV IFRX gained 15.1% to $5.91 as the company announced decision to enter Phase III DEVELOPMENT OF IFX-1 in severe COVID-19 induced pneumonia.
• Genprex, Inc. GNPX surged 14.8% to $3.5596 after National Institute of Health awarded a research grant of $2.59 million to the University of Pittsburgh for diabetes gene therapy technology licensed by Genprex.
• Northern Dynasty Minerals Ltd. NAK rose 13.8% to $2.2299 following a 16% surge in the prior session.
• Afya Limited AFYA gained 13.4% to $26.88 after the company reported the acquisition of 100% total share capital of PebMed.
• Miragen Therapeutics Inc MGEN climbed 13.2% to $1.15 after the company announced on Monday it has regained compliance with Nasdaq listing requirements.
• CTI BioPharma Corp. CTIC shares rose 13% to $1.8066 after gaining more than 7% on Monday.
• Computer Task Group, Incorporated CTG gained 13% to $4.7950 after reporting Q2 results.
• First Hawaiian, Inc. FHB gained 12.2% to $17.42. First Hawaiian will replace Emergent BioSolutions in the S&P SmallCap 600 on Friday, July 24.
• Lexicon Pharmaceuticals, Inc. LXRX climbed 11.2% to $2.3350 after the company reported the results from the phase 3 data from four phase 3 Sotagliflozin studies in type 2 diabetes met their primary objectives of lowering A1C in patients with type 2 diabetes.
• Synaptics, Incorporated SYNA climbed 11% to $79.90 after the company agreed to acquire DisplayLink for $305 million in cash.
• Oragenics, Inc. OGEN rose 9.2% to $1.6050 after gaining over 32% on Monday. Oragenics discontinued its AG013 oral mucositis development program earlier this month and planned to use available cash to continue the development of its TerraCoV2 coronavirus vaccine candidate.
• BioHiTech Global Inc BHTG rose 7.1% to $2.13 after Carnival reinitiated its installation program of the company's Revolution Series Digesters onboard its ships.
• Cerecor Inc CERC gained 6% to $2.92 after the company said first patient has been enrolled in multicenter proof-of-concept study evaluating CERC-002 for COVID-19 ARDS.
• Philip Morris International Inc. PM climbed 4.6% to $76.22 after the company reported better-than-expected Q2 results. The company also issued FY20 EPS guidance above analyst estimates.

Check out these big penny stock gainers and losers

Losers

BIO-key International, Inc. BKYI shares dipped 29.5% to $0.6123 after the company reported pricing of $21.6 million underwritten public offering.

Heat Biologics, Inc. HTBX shares declined 21.8% to $2.8301 after jumping 47% on Monday.

ACADIA Pharmaceuticals Inc. ACAD fell 18.4% to $45.19 after the company announced negative top-line results from its 298 patient Phase 3 CLARITY study, which combined two identical, double-blind, placebo-controlled studies evaluating the efficacy, safety and tolerability of pimavanserin as an adjunctive treatment for major depressive disorder. The company said the study did not meet the primary endpoint with statistical significance.

Tiziana Life Sciences PLC TLSA fell 18.3% to $10.00.

Ashford Hospitality Trust, Inc. AHT shares dropped 17.3% to $5.01 after declining 13% on Monday.

PDS Biotechnology Corporation PDSB fell 15% to $3.59 after climbing 39% on Monday.

Cytosorbents Corp CTSO fell 15% to $9.82 after the company reported a proposed $40 million common stock offering. Cytosorbents announced preliminary second-quarter revenues of $9.8 million, a 61% year-over-year increase.

VBI Vaccines Inc. VBIV dropped 14.2% to $5.15.

Just Energy Group Inc. JE fell 14% to $0.4645. Just Energy shares jumped 52% on Monday after the company received an interim order from the Ontario Superior Court of Justice which grants a stay of proceedings for the company's recapitalization plan.

Dynavax Technologies Corporation DVAX shares dipped 13.2% to $10.15. The company last week announced a collaboration with Mount Sinai to develop a universal flu vaccine candidate with CpG 1018 adjuvant.

Houghton Mifflin Harcourt Company HMHC dropped 12.5% to $2.065 after declining 16% on Monday.

Option Care Health Inc OPCH 11.8% to $14.11 after the company reported a proposed offering of $350 million of shares of common stock.

Qiwi plc QIWI dipped 11.3% to $17.03 after the company reported a secondary public offering of 6.8 million Class B shares represented by ADS's.

Kiniksa Pharmaceuticals Ltd KNSA fell 11% to $21.28 after the company reported a common stock offering of $100 million.

IMV Inc. IMV fell 10.6% to $5.32. On Monday, IMV appointed Michael P. Bailey to its Board of Directors.

Idera Pharmaceuticals, Inc. IDRA fell 9.9% to $2.38 after climbing 19% on Monday. Idera Pharmaceuticals, last week, reported a private placement of up to $20 million.

Boxlight Corporation BOXL fell 8.5% to $2.67 after dropping over 20% on Monday.

Castor Maritime Inc. CTRM fell 7.5% to $0.2110 after declining 8% on Monday. Castor Maritime reported closing of $17.3 million registered direct offering last week.

Pieris Pharmaceuticals Inc PIRS fell 6.4% to $3.07 after the company said its phase 1 studies of PRS-343 have been placed on partial clinical hold by the FDA.